Use of Public Human Genetic Variant Databases to Support Clinical Validity for Genetic and Genomic-Based IVDs

This FDA guidance document provides recommendations and regulatory information for the medical device industry. It was issued by the Center for Devices and Radiological Health (CDRH) in collaboration with the Center for Biologics Evaluation and Research (CBER).

Document Details

• Issuing Authority: FDA CDRH/CBER
• Status: Final
• Topic Area: IVD & Diagnostics
• Date: 2018-04-01

Access the Full Document

View on FDA.gov →

Source: U.S. Food and Drug Administration (FDA). This content is provided for informational purposes. Always refer to the official FDA document for the most current version.